Answers are grounded in this paper and cite their sources.
Proteolysis-targeting chimeras (PROTACs) represent a promising therapeutic strategy, yet rational linker design is limited by inadequate theoretical guidance. Herein, we report PotentialLinker, a novel reinforcement learning framework for PROTAC linker optimization that uses a normalized weighted harmonic mean (NWHM) score to predict degradation activity. Benchmarking on ternary structures confirms its performance without precomputed protein−protein complexes. In case studies of STAT3/RIPK1, it recapitulated structure−activity relationships (SAR) and recommended appropriate E3 ligases. Then, conducted by PotentialLinker, a potent FGFR4 degrader D11 was obtained (DC50 = 56.23 nM, Dmax = 89.58%). Due to its covalent interacting with the unique Cys552 in FGFR4, D11 possesses excellent FGFR4 selectivity. Furthermore, D11 also demonstrated favorable oral bioavailability (F = 21.3%) and potent antitumor efficacy (TGI = 87.07%) with acceptable tolerability in vivo. Taken together, this framework effectively bridges degradation theory and practical PROTAC design, which can be utilized for the rational design of PROTAC-based therapeutic agents.
No takes yet. Share an insight, caveat, or question.
Yin et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: